MDVN: Medivation, Inc. Yearly Stock Returns

Year	Beginning Price	Ending Price	Gain or Loss	Percent Gain or Loss
1997	9.00	9.125	0.125	1.39%
1998	9.125	9.125	0	0.00%
1999	9.125	1.375	-7.75	-84.93%
2000	1.375	1.125	-0.25	-18.18%
2001	1.125	1.30	0.175	15.56%
2002	1.30	0.70	-0.60	-46.15%
2003	0.70	1.01	0.31	44.29%
2004	1.01	3.00	1.99	197.03%
2005	3.00	2.54	-0.46	-15.33%
2006	2.54	15.82	13.28	522.83%
2007	15.82	14.40	-1.42	-8.98%
2008	14.40	14.57	0.17	1.18%
2009	14.57	37.65	23.08	158.41%
2010	37.65	15.17	-22.48	-59.71%
2011	15.17	46.11	30.94	203.96%
2012	46.11	102.32*	56.21	121.90%
2013	51.16	63.82	12.66	24.75%
2014	63.82	99.61	35.79	56.08%
2015	99.61	96.68*	-2.93	-2.94%
2016	48.34	81.50*	33.16	68.60%

*The 2012 ending price for Medivation, Inc. has been adjusted for a 2 for 1 stock split.
*The 2015 ending price for Medivation, Inc. has been adjusted for a 2 for 1 stock split.
*In 2016, Pfizer (PFE) completed its acquisition of Medivation (MDVN) for $81.50 per share.

Calculations do not reflect any dividends paid or any stock spinoffs from original stock. Taxes and commissions are not factored into calculations. Data is property of 1stock1 and written permission must be granted before redistributing any data (in part or in whole).